We recently reported that AYA breast cancer incidence differs from that in older women, with AYAs having higher proportions of HR+/HER2+, triple-negative, and HR-/HER2+ breast cancer subtypes and higher proportions of patients of non-White race/ethnicity than older women [6]. The gene discussed is ERBB2; the disease is breast cancer.